30 results on '"Stefano Borsa"'
Search Results
2. Systemic immune response in young and elderly patients after traumatic brain injury
- Author
-
Marta Magatti, Francesca Pischiutta, Fabrizio Ortolano, Anna Pasotti, Enrico Caruso, Anna Cargnoni, Andrea Papait, Franco Capuzzi, Tommaso Zoerle, Marco Carbonara, Nino Stocchetti, Stefano Borsa, Marco Locatelli, Elisa Erba, Daniele Prati, Antonietta R Silini, Elisa R Zanier, and Ornella Parolini
- Subjects
Aging ,Immune cells ,Systemic immune cells ,Traumatic brain injury ,Elderly ,Young ,Immunologic diseases. Allergy ,RC581-607 ,Geriatrics ,RC952-954.6 - Abstract
Abstract Background Traumatic brain injury (TBI) is a leading cause of death and long-term disability worldwide. In addition to primary brain damage, systemic immune alterations occur, with evidence for dysregulated immune responses in aggravating TBI outcome and complications. However, immune dysfunction following TBI has been only partially understood, especially in the elderly who represent a substantial proportion of TBI patients and worst outcome. Therefore, we aimed to conduct an in-depth immunological characterization of TBI patients, by evaluating both adaptive (T and B lymphocytes) and innate (NK and monocytes) immune cells of peripheral blood mononuclear cells (PBMC) collected acutely ( 65 yo) patients, compared to age-matched controls, and also the levels of inflammatory biomarkers. Results Our data show that young respond differently than elderly to TBI, highlighting the immune unfavourable status of elderly compared to young patients. While in young only CD4 T lymphocytes are activated by TBI, in elderly both CD4 and CD8 T cells are affected, and are induced to differentiate into subtypes with low cytotoxic activity, such as central memory CD4 T cells and memory precursor effector CD8 T cells. Moreover, TBI enhances the frequency of subsets that have not been previously investigated in TBI, namely the double negative CD27- IgD- and CD38-CD24- B lymphocytes, and CD56dim CD16- NK cells, both in young and elderly patients. TBI reduces the production of pro-inflammatory cytokines TNF-α and IL-6, and the expression of HLA-DM, HLA-DR, CD86/B7-2 in monocytes, suggesting a compromised ability to drive a pro-inflammatory response and to efficiently act as antigen presenting cells. Conclusions We described the acute immunological response induced by TBI and its relation with injury severity, which could contribute to pathologic evolution and possibly outcome. The focus on age-related immunological differences could help design specific therapeutic interventions based on patients’ characteristics.
- Published
- 2023
- Full Text
- View/download PDF
3. A Deep Learning Model for Preoperative Differentiation of Glioblastoma, Brain Metastasis, and Primary Central Nervous System Lymphoma: An External Validation Study
- Author
-
Leonardo Tariciotti, Davide Ferlito, Valerio M. Caccavella, Andrea Di Cristofori, Giorgio Fiore, Luigi G. Remore, Martina Giordano, Giulia Remoli, Giulio Bertani, Stefano Borsa, Mauro Pluderi, Paolo Remida, Gianpaolo Basso, Carlo Giussani, Marco Locatelli, and Giorgio Carrabba
- Subjects
brain metastases ,deep learning ,glioblastoma ,machine learning ,primary central nervous system lymphoma ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
(1) Background: Neuroimaging differentiation of glioblastoma, primary central nervous system lymphoma (PCNSL) and solitary brain metastasis (BM) represents a diagnostic and therapeutic challenge in neurosurgical practice, expanding the burden of care and exposing patients to additional risks related to further invasive procedures and treatment delays. In addition, atypical cases and overlapping features have not been entirely addressed by modern diagnostic research. The aim of this study was to validate a previously designed and internally validated ResNet101 deep learning model to differentiate glioblastomas, PCNSLs and BMs. (2) Methods: We enrolled 126 patients (glioblastoma: n = 64; PCNSL: n = 27; BM: n = 35) with preoperative T1Gd-MRI scans and histopathological confirmation. Each lesion was segmented, and all regions of interest were exported in a DICOM dataset. A pre-trained ResNet101 deep neural network model implemented in a previous work on 121 patients was externally validated on the current cohort to differentiate glioblastomas, PCNSLs and BMs on T1Gd-MRI scans. (3) Results: The model achieved optimal classification performance in distinguishing PCNSLs (AUC: 0.73; 95%CI: 0.62–0.85), glioblastomas (AUC: 0.78; 95%CI: 0.71–0.87) and moderate to low ability in differentiating BMs (AUC: 0.63; 95%CI: 0.52–0.76). The performance of expert neuro-radiologists on conventional plus advanced MR imaging, assessed by retrospectively reviewing the diagnostic reports of the selected cohort of patients, was found superior in accuracy for BMs (89.69%) and not inferior for PCNSL (82.90%) and glioblastomas (84.09%). (4) Conclusions: We investigated whether the previously published deep learning model was generalizable to an external population recruited at a different institution—this validation confirmed the consistency of the model and laid the groundwork for future clinical applications in brain tumour classification. This artificial intelligence-based model might represent a valuable educational resource and, if largely replicated on prospective data, help physicians differentiate glioblastomas, PCNSL and solitary BMs, especially in settings with limited resources.
- Published
- 2022
- Full Text
- View/download PDF
4. The impact of COVID-19 pandemic on surgical neuro-oncology: A survey from the Italian society of neurosurgery (SINch)
- Author
-
Luca Zanin, Tamara Ius, Pier Paolo Panciani, Felice Esposito, Andrea Gori, Marco Maria Fontanella, Maria Pia Tropeano, Antonino Raco, Filippo Flavio Angileri, Giovanni Sabatino, Alessandro Olivi, Vincenzo Esposito, Federico Pessina, Edoardo Agosti, Salvatore Aiello, Denis Aiudi, Danilo Aleo, Roberto Altieri, Rosina Amoroso, Anna Maria Auricchio, Giuseppe Barbagallo, Andrea Barbanera, Giacomo Beggio, Andrea Bianco, Riccardo Boccaletti, Stefano Borsa, Giuseppe Canova, Paolo Cappabianca, Manuela Caroli, Michele Alessandro Cavallo, Francesco Certo, Marcella Chimenti, Franco Chioffi, Valentina Cioffi, Fabio Cofano, Christian Cossandi, Giancarlo D’Andrea, Raffaele De Falco, Alessandro D'Elia, Giuseppe Maria Della Pepa, Alessandro Della Puppa, Attilio Della Torre, Paolo Ferroli, Diego Garbossa, Antonino Germanò, Alessandra Giaquinta, Franco Guida, Maurizio Iacoangeli, Domenico Gerardo Iacopino, Angelo Lavano, Giuseppe Maimone, Vincenza Maiola, Rosario Mauferi, Alessandro Melatini, Mario Moro, Domenico Murrone, Giovanni Muscas, Piero Andrea Oppido, Fabrizio Pignotti, Domenico Policicchio, Piermassimo Proto, Paolo Quaglietta, Giulia Renisi, Luca Ricciardi, Francesco Romeo, Marta Rossetto, Alba Scerrati, Andreas Schwarz, Miran Skrap, Carlo Somma, Teresa Somma, Giannantonio Spena, Stefano Telera, Luigino Tosatto, Francesco Volpin, Lorenzo Volpin, and Cesare Zoia
- Subjects
COVID-19 ,Neuroncology ,SINch ,Survey ,Surgery ,RD1-811 ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Background: The COVID-19 pandemic and its impact on hospitals' activity and organization has imposed a vast change in standard neurosurgical oncology practice to accommodate for shifting resources. Aims: This investigation aims to analyse the nationwide capability in reorganizing the surgical neuro-oncological activity during the COVID-19 pandemic to evaluate whether COVID-19-pandemic influenced the surgical management in these patients. Method: A web-based dataset model organized by the Italian Neurosurgical Society (SINCh) was sent to all the Italian neurosurgical departments in May 2021, requesting to report the types and numbers of surgical procedures performed in the pre-pandemic period (from March 9th 2019 to March 9th 2020) compared to the pandemic period (from March 10th 2020 to March 10th 2021). Results: This multicentre investigation included the surgical activity of 35 Italian Neurosurgical Departments in a pre-pandemic year versus a pandemic year. During the COVID period, 699 fewer neuro-oncological patients were operated on than in the pre-COVID period. We noted a slight increase in urgency and a more severe decrease in elective and benign pathology. None of these differences was statistically significant. Surgically treated patients who tested positive for SARS-CoV-2 were 36, of which 11 died. Death was found to be COVID-related only in 2 cases. Conclusion: The reorganization of the Italian Neurosurgical Departments was able to guarantee a redistribution of the CNS tumors during the inter-pandemic periods, demonstrating that patients even in the pandemic era could be treated without compromising the efficacy and safety of the surgical procedure.
- Published
- 2023
- Full Text
- View/download PDF
5. Indocyanine Green use in endoscopic trans-sphenoidal surgery
- Author
-
Antonio D'ammando, Leonardo Tariciotti, Giulio Andrea Bertani, Petra Bintintan Socaciu, Luigi Schisano, Stefano Borsa, Dario Gagliano, and Marco Locatelli
- Subjects
Neurology. Diseases of the nervous system ,RC346-429 - Published
- 2023
- Full Text
- View/download PDF
6. Indication and eligibility of glioma patients for awake surgery: A scoping review by a multidisciplinary perspective
- Author
-
Giorgio Fiore, Giorgia Abete-Fornara, Arianna Forgione, Leonardo Tariciotti, Mauro Pluderi, Stefano Borsa, Cristina Bana, Filippo Cogiamanian, Maurizio Vergari, Valeria Conte, Manuela Caroli, Marco Locatelli, and Giulio Andrea Bertani
- Subjects
awake ,awake surgery ,eligibility ,indication ,gliomas ,brain tumors ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
BackgroundAwake surgery (AS) permits intraoperative mapping of cognitive and motor functions, allowing neurosurgeons to tailor the resection according to patient functional boundaries thus preserving long-term patient integrity and maximizing extent of resection. Given the increased risks of the awake scenario, the growing importance of AS in surgical practice favored the debate about patient selection concerning both indication and eligibility criteria. Nonetheless, a systematic investigation is lacking in the literature.ObjectiveTo provide a scoping review of the literature concerning indication and eligibility criteria for AS in patients with gliomas to answer the questions:1) "What are the functions mostly tested during AS protocols?" and 2) "When and why should a patient be excluded from AS?".Materials and methodsPertinent studies were retrieved from PubMed, PsycArticles and Cochrane Central Register of Controlled Trials (CENTRAL), published until April 2021 according to the PRISMA Statement Extension for Scoping Reviews. The retrieved abstracts were checked for the following features being clearly stated: 1) the population described as being composed of glioma(LGG or HGG) patients; 2) the paper had to declare which cognitive or sensorimotor function was tested, or 2bis)the decisional process of inclusion/exclusion for AS had to be described from at least one of the following perspectives: neurosurgical, neurophysiological, anesthesiologic and psychological/neuropsychological.ResultsOne hundred and seventy-eight studies stated the functions being tested on 8004 patients. Language is the main indication for AS, even if tasks and stimulation techniques changed over the years. It is followed by monitoring of sensorimotor and visuospatial pathways. This review demonstrated an increasing interest in addressing other superior cognitive functions, such as executive functions and emotions. Forty-five studies on 2645 glioma patients stated the inclusion/exclusion criteria for AS eligibility. Inability to cooperate due to psychological disorder(i.e. anxiety),severe language deficits and other medical conditions(i.e.cardiovascular diseases, obesity, etc.)are widely reported as exclusion criteria for AS. However, a very few papers gave scale exact cut-off. Likewise, age and tumor histology are not standardized parameters for patient selection.ConclusionGiven the broad spectrum of functions that might be safely and effectively monitored via AS, neurosurgeons and their teams should tailor intraoperative testing on patient needs and background as well as on tumor location and features. Whenever the aforementioned exclusion criteria are not fulfilled, AS should be strongly considered for glioma patients.
- Published
- 2022
- Full Text
- View/download PDF
7. Prevention of Post-Operative Pain after Elective Brain Surgery: A Meta-Analysis of Randomized Controlled Trials
- Author
-
Giorgio Fiore, Edoardo Porto, Mauro Pluderi, Antonella Maria Ampollini, Stefano Borsa, Federico Giuseppe Legnani, Davide Giampiccolo, Anna Miserocchi, Giulio Andrea Bertani, Francesco DiMeco, and Marco Locatelli
- Subjects
pain ,craniotomy ,acute pain ,brain surgery ,post-operative pain ,treatment ,Medicine (General) ,R5-920 - Abstract
Background and Objective: To analyze the effects of several drug for pain prevention in adults undergoing craniotomy for elective brain surgery. Material and Methods: A systematic review and meta-analysis were conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. The inclusion criteria were limited to randomized controlled trials (RCTs) that evaluated the effectiveness of pharmacological treatments for preventing post-operative pain in adults (aged 18 years or older) undergoing craniotomies. The main outcome measures were represented by the mean differences in validated pain intensity scales administered at 6 h, 12 h, 24 h and 48 h post-operatively. The pooled estimates were calculated using random forest models. The risk of bias was evaluated using the RoB2 revised tool, and the certainty of evidence was assessed according to the GRADE guidelines. Results: In total, 3359 records were identified through databases and registers’ searching. After study selection, 29 studies and 2376 patients were included in the meta-analysis. The overall risk of bias was low in 78.5% of the studies included. The pooled estimates of the following drug classes were provided: NSAIDs, acetaminophen, local anesthetics and steroids for scalp infiltration and scalp block, gabapentinoids and agonists of adrenal receptors. Conclusions: High-certainty evidence suggests that NSAIDs and acetaminophen may have a moderate effect on reducing post-craniotomy pain 24 h after surgery compared to control and that ropivacaine scalp block may have a bigger impact on reducing post-craniotomy pain 6 h after surgery compared to control. Moderate-certainty evidence indicates that NSAIDs may have a more remarkable effect on reducing post-craniotomy pain 12 h after surgery compared to control. No moderate-to-high-certainty evidence indicates effective treatments for post-craniotomy pain prevention 48 h after surgery.
- Published
- 2023
- Full Text
- View/download PDF
8. A Deep Learning Model for Preoperative Differentiation of Glioblastoma, Brain Metastasis and Primary Central Nervous System Lymphoma: A Pilot Study
- Author
-
Leonardo Tariciotti, Valerio M. Caccavella, Giorgio Fiore, Luigi Schisano, Giorgio Carrabba, Stefano Borsa, Martina Giordano, Paolo Palmisciano, Giulia Remoli, Luigi Gianmaria Remore, Mauro Pluderi, Manuela Caroli, Giorgio Conte, Fabio Triulzi, Marco Locatelli, and Giulio Bertani
- Subjects
brain metastases ,deep learning ,glioblastoma ,machine learning ,primary central nervous system lymphoma (PCNSL) ,artificial intelligence ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
BackgroundNeuroimaging differentiation of glioblastoma, primary central nervous system lymphoma (PCNSL) and solitary brain metastasis (BM) remains challenging in specific cases showing similar appearances or atypical features. Overall, advanced MRI protocols have high diagnostic reliability, but their limited worldwide availability, coupled with the overlapping of specific neuroimaging features among tumor subgroups, represent significant drawbacks and entail disparities in the planning and management of these oncological patients.ObjectiveTo evaluate the classification performance metrics of a deep learning algorithm trained on T1-weighted gadolinium-enhanced (T1Gd) MRI scans of glioblastomas, atypical PCNSLs and BMs.Materials and MethodsWe enrolled 121 patients (glioblastoma: n=47; PCNSL: n=37; BM: n=37) who had undergone preoperative T1Gd-MRI and histopathological confirmation. Each lesion was segmented, and all ROIs were exported in a DICOM dataset. The patient cohort was then split in a training and hold-out test sets following a 70/30 ratio. A Resnet101 model, a deep neural network (DNN), was trained on the training set and validated on the hold-out test set to differentiate glioblastomas, PCNSLs and BMs on T1Gd-MRI scans.ResultsThe DNN achieved optimal classification performance in distinguishing PCNSLs (AUC: 0.98; 95%CI: 0.95 - 1.00) and glioblastomas (AUC: 0.90; 95%CI: 0.81 - 0.97) and moderate ability in differentiating BMs (AUC: 0.81; 95%CI: 0.70 - 0.95). This performance may allow clinicians to correctly identify patients eligible for lesion biopsy or surgical resection.ConclusionWe trained and internally validated a deep learning model able to reliably differentiate ambiguous cases of PCNSLs, glioblastoma and BMs by means of T1Gd-MRI. The proposed predictive model may provide a low-cost, easily-accessible and high-speed decision-making support for eligibility to diagnostic brain biopsy or maximal tumor resection in atypical cases.
- Published
- 2022
- Full Text
- View/download PDF
9. Towards a common language in neurosurgical outcome evaluation: the NEON (NEurosurgical Outcome Network) proposal
- Author
-
Ferroli, Paolo, Schiavolin, Silvia, Mariniello, Arianna, Acerbi, Francesco, Restelli, Francesco, Schiariti, Marco, LA Corte, Emanuele, Falco, Jacopo, Levi, Vincenzo, Dimeco, Francesco, Assietti, Roberto, Bongetta, Daniele, V Colombo, Elena, Bellocchi, Silvio, Sangiorgi, Simone, Bistazzoni, Simona, Polosa, Maria, I Orru, Maria, Spena, Giannantonio, Bernucci, Claudio, M Sicignano, Angelo, Fanti, Andrea, Brembilla, Carlo, Resmini, Bruno, Costi, Emanuele, Cenzato, Marco, Talamonti, Giuseppe, Bottini, Gabriella, Scarpa, Pina, Bollani, Alessandra, Querzola, Matteo, Palmas, Giulio, DE Gonda, Federico, Bosio, Lorenzo, Egidi, Marcello, Tardivo, Valentina, Fioravanti, Antonio, Subacchi, Sara, Fontanella, Marco, Biroli, Antonio, Cereda, Claudio, Paolo Panciani, Pier, Bergomi, Riccardo, Pertichetti, Marta, Tancioni, Flavio, Bona, Alberto, A Tartara, Fulvio, Fornari, Maurizio, Pessina, Federico, Lasio, Giovanni, Cardia, Andrea, Servadei, Franco, Riva, Marco, Casarotti, Alessandra, Giussani, Carlo, Fiori, Leonardo, Mazzoleni, Fabio, Vaiani, Simona, Carrabba, Giorgio, DI Cristofori, Andrea, P Sganzerla, Erik, Vimercati, Alberto, Isella, Valeria, Mauri, Ilaria, Incerti, Michele, Sicuri, Giovanni, Miramonti, Valentina, Stefini, Roberto, Spagnoli, Diego, Piparo, Maurizio, Grimod, Gianluca, Regazzoni, Rossana, Vismara, Daniela, Mazzeo, Lucio, Monti, Emanuele, Franzin, Alberto, Vivaldi, Oscar, Maietti, Alessandra, Pini, Elisa, Servello, Domenico, Zekaj, Edvin, DE Michele, Sara, Locatelli, Marco, Borsa, Stefano, Grimoldi, Nadia, Caroli, Manuela, Tariciotti, Leonardo, Abete-Fornara, Giorgia, Vitale, Mario, Leonardi, Matilde, Broggi, Morgan, Paolo Ferroli, Silvia Schiavolin, Arianna Mariniello, Francesco Acerbi, Francesco Restelli, Marco Schiariti, Emanuele LA Corte, Jacopo Falco, Vincenzo Levi, Francesco Dimeco, Roberto Assietti, Daniele Bongetta, Elena V Colombo, Silvio Bellocchi, Simone Sangiorgi, Simona Bistazzoni, Maria Polosa, Maria I Orru, Giannantonio Spena, Claudio Bernucci, Angelo M Sicignano, Andrea Fanti, Carlo Brembilla, Bruno Resmini, Emanuele Costi, Marco Cenzato, Giuseppe Talamonti, Gabriella Bottini, Pina Scarpa, Alessandra Bollani, Matteo Querzola, Giulio Palmas, Federico DE Gonda, Lorenzo Bosio, Marcello Egidi, Valentina Tardivo, Antonio Fioravanti, Sara Subacchi, Marco Fontanella, Antonio Biroli, Claudio Cereda, Pier Paolo Panciani, Riccardo Bergomi, Marta Pertichetti, Flavio Tancioni, Alberto Bona, Fulvio A Tartara, Maurizio Fornari, Federico Pessina, Giovanni Lasio, Andrea Cardia, Franco Servadei, Marco Riva, Alessandra Casarotti, Carlo Giussani, Leonardo Fiori, Fabio Mazzoleni, Simona Vaiani, Giorgio Carrabba, Andrea DI Cristofori, Erik P Sganzerla, Alberto Vimercati, Valeria Isella, Ilaria Mauri, Michele Incerti, Giovanni Sicuri, Valentina Miramonti, Roberto Stefini, Diego Spagnoli, Maurizio Piparo, Gianluca Grimod, Rossana Regazzoni, Daniela Vismara, Lucio Mazzeo, Emanuele Monti, Alberto Franzin, Oscar Vivaldi, Alessandra Maietti (ORCID:0000-0002-9819-7037), Elisa Pini, Domenico Servello, Edvin Zekaj, Sara DE Michele, Marco Locatelli, Stefano Borsa, Nadia Grimoldi, Manuela Caroli, Leonardo Tariciotti, Giorgia Abete-Fornara, Mario Vitale, Matilde Leonardi, Morgan Broggi, Ferroli, Paolo, Schiavolin, Silvia, Mariniello, Arianna, Acerbi, Francesco, Restelli, Francesco, Schiariti, Marco, LA Corte, Emanuele, Falco, Jacopo, Levi, Vincenzo, Dimeco, Francesco, Assietti, Roberto, Bongetta, Daniele, V Colombo, Elena, Bellocchi, Silvio, Sangiorgi, Simone, Bistazzoni, Simona, Polosa, Maria, I Orru, Maria, Spena, Giannantonio, Bernucci, Claudio, M Sicignano, Angelo, Fanti, Andrea, Brembilla, Carlo, Resmini, Bruno, Costi, Emanuele, Cenzato, Marco, Talamonti, Giuseppe, Bottini, Gabriella, Scarpa, Pina, Bollani, Alessandra, Querzola, Matteo, Palmas, Giulio, DE Gonda, Federico, Bosio, Lorenzo, Egidi, Marcello, Tardivo, Valentina, Fioravanti, Antonio, Subacchi, Sara, Fontanella, Marco, Biroli, Antonio, Cereda, Claudio, Paolo Panciani, Pier, Bergomi, Riccardo, Pertichetti, Marta, Tancioni, Flavio, Bona, Alberto, A Tartara, Fulvio, Fornari, Maurizio, Pessina, Federico, Lasio, Giovanni, Cardia, Andrea, Servadei, Franco, Riva, Marco, Casarotti, Alessandra, Giussani, Carlo, Fiori, Leonardo, Mazzoleni, Fabio, Vaiani, Simona, Carrabba, Giorgio, DI Cristofori, Andrea, P Sganzerla, Erik, Vimercati, Alberto, Isella, Valeria, Mauri, Ilaria, Incerti, Michele, Sicuri, Giovanni, Miramonti, Valentina, Stefini, Roberto, Spagnoli, Diego, Piparo, Maurizio, Grimod, Gianluca, Regazzoni, Rossana, Vismara, Daniela, Mazzeo, Lucio, Monti, Emanuele, Franzin, Alberto, Vivaldi, Oscar, Maietti, Alessandra, Pini, Elisa, Servello, Domenico, Zekaj, Edvin, DE Michele, Sara, Locatelli, Marco, Borsa, Stefano, Grimoldi, Nadia, Caroli, Manuela, Tariciotti, Leonardo, Abete-Fornara, Giorgia, Vitale, Mario, Leonardi, Matilde, Broggi, Morgan, Paolo Ferroli, Silvia Schiavolin, Arianna Mariniello, Francesco Acerbi, Francesco Restelli, Marco Schiariti, Emanuele LA Corte, Jacopo Falco, Vincenzo Levi, Francesco Dimeco, Roberto Assietti, Daniele Bongetta, Elena V Colombo, Silvio Bellocchi, Simone Sangiorgi, Simona Bistazzoni, Maria Polosa, Maria I Orru, Giannantonio Spena, Claudio Bernucci, Angelo M Sicignano, Andrea Fanti, Carlo Brembilla, Bruno Resmini, Emanuele Costi, Marco Cenzato, Giuseppe Talamonti, Gabriella Bottini, Pina Scarpa, Alessandra Bollani, Matteo Querzola, Giulio Palmas, Federico DE Gonda, Lorenzo Bosio, Marcello Egidi, Valentina Tardivo, Antonio Fioravanti, Sara Subacchi, Marco Fontanella, Antonio Biroli, Claudio Cereda, Pier Paolo Panciani, Riccardo Bergomi, Marta Pertichetti, Flavio Tancioni, Alberto Bona, Fulvio A Tartara, Maurizio Fornari, Federico Pessina, Giovanni Lasio, Andrea Cardia, Franco Servadei, Marco Riva, Alessandra Casarotti, Carlo Giussani, Leonardo Fiori, Fabio Mazzoleni, Simona Vaiani, Giorgio Carrabba, Andrea DI Cristofori, Erik P Sganzerla, Alberto Vimercati, Valeria Isella, Ilaria Mauri, Michele Incerti, Giovanni Sicuri, Valentina Miramonti, Roberto Stefini, Diego Spagnoli, Maurizio Piparo, Gianluca Grimod, Rossana Regazzoni, Daniela Vismara, Lucio Mazzeo, Emanuele Monti, Alberto Franzin, Oscar Vivaldi, Alessandra Maietti (ORCID:0000-0002-9819-7037), Elisa Pini, Domenico Servello, Edvin Zekaj, Sara DE Michele, Marco Locatelli, Stefano Borsa, Nadia Grimoldi, Manuela Caroli, Leonardo Tariciotti, Giorgia Abete-Fornara, Mario Vitale, Matilde Leonardi, and Morgan Broggi
- Abstract
BACKGROUNDː To achieve a consensus on the minimum set of outcome measures and predictors to be used in the neurosurgical practice and on the timing of outcome assessment. METHODSː A consensus building approach was employed. All neurosurgical departments in Lombardy (Italy) were invited to participate by the Fondazione IRCCS Istituto Neurologico Carlo Besta. Three workshops were organized during which a multidisciplinary group called Neurosurgical Outcome Network (NEON) was created and the methodology to select outcome measures, predictors, and timing of outcome assessment was established. Eight working groups were created for the different neurosurgical diseases (neuro-oncological, skull base, vascular, traumatic, spinal, peripheral nervous system, malformation, functional) and 8 workshops were organized to identify the outcome measures and predictors specific for each of the neurosurgical diseases based on the experts’ clinical practice and the existing literature. RESULTSː A total of 20 neurosurgical departments participated in this study. Specific outcome measures, predictors and the timing of outcome assessment were identified for each of the 8 neurosurgical diseases. Moreover, a list of variables common to all pathologies were identified by the NEON group as further data to be collected. CONCLUSIONSː A consensus on the minimum set of outcome measures and predictors and the timing of outcome assessments for 8 neurosurgical diseases was achieved by a group of neurosurgeons of the Lombardy region, called NEON. These sets could be used in future studies for a more homogeneous data collection and as a starting point to reach further agreement also at national and international level.
- Published
- 2023
10. Predicting tumor consistency and extent of resection in non-functioning pituitary tumors
- Author
-
Giorgio Fiore, Giulio Andrea Bertani, Giorgio Conte, Emanuele Ferrante, Leonardo Tariciotti, Elisabetta Kuhn, Letterio Runza, Mauro Pluderi, Stefano Borsa, Manuela Caroli, Elisa Sala, Giulia Platania, Karin Kremenova, Stefano Ferrero, Fabio Maria Triulzi, Giovanna Mantovani, and Marco Locatelli
- Subjects
Endocrinology ,Endocrinology, Diabetes and Metabolism - Published
- 2023
- Full Text
- View/download PDF
11. Towards a common language in neurosurgical outcome evaluation: the NEON (NEurosurgical Outcome Network) proposal
- Author
-
Paolo FERROLI, Silvia SCHIAVOLIN, Arianna MARINIELLO, Francesco ACERBI, Francesco RESTELLI, Marco SCHIARITI, Emanuele LA CORTE, Jacopo FALCO, Vincenzo LEVI, Francesco DIMECO, Roberto ASSIETTI, Daniele BONGETTA, Elena V. COLOMBO, Silvio BELLOCCHI, Simone SANGIORGI, Simona BISTAZZONI, Maria POLOSA, Maria I. ORRU, Giannantonio SPENA, Claudio BERNUCCI, Angelo M. SICIGNANO, Andrea FANTI, Carlo BREMBILLA, Bruno RESMINI, Emanuele COSTI, Marco CENZATO, Giuseppe TALAMONTI, Gabriella BOTTINI, Pina SCARPA, Alessandra BOLLANI, Matteo QUERZOLA, Giulio PALMAS, Federico DE GONDA, Lorenzo BOSIO, Marcello EGIDI, Valentina TARDIVO, Antonio FIORAVANTI, Sara SUBACCHI, Marco FONTANELLA, Antonio BIROLI, Claudio CEREDA, Pier Paolo PANCIANI, Riccardo BERGOMI, Marta PERTICHETTI, Flavio TANCIONI, Alberto BONA, Fulvio A. TARTARA, Maurizio FORNARI, Federico PESSINA, Giovanni LASIO, Andrea CARDIA, Franco SERVADEI, Marco RIVA, Alessandra CASAROTTI, Carlo GIUSSANI, Leonardo FIORI, Fabio MAZZOLENI, Simona VAIANI, Giorgio CARRABBA, Andrea DI CRISTOFORI, Erik P. SGANZERLA, Alberto VIMERCATI, Valeria ISELLA, Ilaria MAURI, Michele INCERTI, Giovanni SICURI, Valentina MIRAMONTI, Roberto STEFINI, Diego SPAGNOLI, Maurizio PIPARO, Gianluca GRIMOD, Rossana REGAZZONI, Daniela VISMARA, Lucio MAZZEO, Emanuele MONTI, Alberto FRANZIN, Oscar VIVALDI, Alessandra MAIETTI, Elisa PINI, Domenico SERVELLO, Edvin ZEKAJ, Sara DE MICHELE, Marco LOCATELLI, Stefano BORSA, Nadia GRIMOLDI, Manuela CAROLI, Leonardo TARICIOTTI, Giorgia ABETE-FORNARA, Mario VITALE, Matilde LEONARDI, Morgan BROGGI, Ferroli, P, Schiavolin, S, Mariniello, A, Acerbi, F, Restelli, F, Schiariti, M, LA Corte, E, Falco, J, Levi, V, Dimeco, F, Assietti, R, Bongetta, D, Colombo, E, Bellocchi, S, Sangiorgi, S, Bistazzoni, S, Polosa, M, Orru, M, Spena, G, Bernucci, C, Sicignano, A, Fanti, A, Brembilla, C, Resmini, B, Costi, E, Cenzato, M, Talamonti, G, Bottini, G, Scarpa, P, Bollani, A, Querzola, M, Palmas, G, DE Gonda, F, Bosio, L, Egidi, M, Tardivo, V, Fioravanti, A, Subacchi, S, Fontanella, M, Biroli, A, Cereda, C, Panciani, P, Bergomi, R, Pertichetti, M, Tancioni, F, Bona, A, Tartara, F, Fornari, M, Pessina, F, Lasio, G, Cardia, A, Servadei, F, Riva, M, Casarotti, A, Giussani, C, Fiori, L, Mazzoleni, F, Vaiani, S, Carrabba, G, DI Cristofori, A, Sganzerla, E, Vimercati, A, Isella, V, Mauri, I, Incerti, M, Sicuri, G, Miramonti, V, Stefini, R, Spagnoli, D, Piparo, M, Grimod, G, Regazzoni, R, Vismara, D, Mazzeo, L, Monti, E, Franzin, A, Vivaldi, O, Maietti, A, Pini, E, Servello, D, Zekaj, E, DE Michele, S, Locatelli, M, Borsa, S, Grimoldi, N, Caroli, M, Tariciotti, L, Abete-Fornara, G, Vitale, M, Leonardi, M, and Broggi, M
- Subjects
predictors ,Consensus ,assessment ,Settore MED/27 - NEUROCHIRURGIA ,Neurosurgery ,Surgery ,neurosurgery ,outcomes ,consensus ,Neurology (clinical) ,Treatment outcome ,Outcome assessment, health care - Abstract
Background: The aim of this study was to achieve a consensus on the minimum set of outcome measures and predictors to be used in the neurosurgical practice and on the timing of outcome assessment. Methods: A consensus building approach was employed. All neurosurgical departments in Lombardy (Italy) were invited to participate by the Carlo Besta Neurologic Institute IRCCS Foundation. Three workshops were organized during which a multidisciplinary group called Neurosurgical Outcome Network (NEON) was created and the methodology to select outcome measures, predictors, and timing of outcome assessment was established. Eight working groups were created for the different neurosurgical diseases (neuro-oncological, skull base, vascular, traumatic, spinal, peripheral nervous system, malformation, functional) and 8 workshops were organized to identify the outcome measures and predictors specific for each of the neurosurgical diseases based on the experts' clinical practice and the existing literature. Results: A total of 20 neurosurgical departments participated in this study. Specific outcome measures, predictors and the timing of outcome assessment were identified for each of the 8 neurosurgical diseases. Moreover, a list of variables common to all pathologies were identified by the NEON group as further data to be collected. Conclusions: A consensus on the minimum set of outcome measures and predictors and the timing of outcome assessments for 8 neurosurgical diseases was achieved by a group of neurosurgeons of the Lombardy region, called NEON. These sets could be used in future studies for a more homogeneous data collection and as a starting point to reach further agreement also at national and international level.
- Published
- 2023
12. A Deep Learning Model for Preoperative Differentiation of Glioblastoma, Brain Metastasis, and Primary Central Nervous System Lymphoma: An External Validation Study
- Author
-
Leonardo Tariciotti, Davide Ferlito, Valerio M. Caccavella, Andrea Di Cristofori, Giorgio Fiore, Luigi G. Remore, Martina Giordano, Giulia Remoli, Giulio Bertani, Stefano Borsa, Mauro Pluderi, Paolo Remida, Gianpaolo Basso, Carlo Giussani, Marco Locatelli, Giorgio Carrabba, Tariciotti, L, Ferlito, D, Caccavella, V, Di Cristofori, A, Fiore, G, Remore, L, Giordano, M, Remoli, G, Bertani, G, Borsa, S, Pluderi, M, Remida, P, Basso, G, Giussani, C, Locatelli, M, and Carrabba, G
- Subjects
machine learning ,primary central nervous system lymphoma ,General Engineering ,glioblastoma ,MED/37 - NEURORADIOLOGIA ,deep learning ,MED/27 - NEUROCHIRURGIA ,brain metastases ,brain metastase - Abstract
(1) Background: Neuroimaging differentiation of glioblastoma, primary central nervous system lymphoma (PCNSL) and solitary brain metastasis (BM) represents a diagnostic and therapeutic challenge in neurosurgical practice, expanding the burden of care and exposing patients to additional risks related to further invasive procedures and treatment delays. In addition, atypical cases and overlapping features have not been entirely addressed by modern diagnostic research. The aim of this study was to validate a previously designed and internally validated ResNet101 deep learning model to differentiate glioblastomas, PCNSLs and BMs. (2) Methods: We enrolled 126 patients (glioblastoma: n = 64; PCNSL: n = 27; BM: n = 35) with preoperative T1Gd-MRI scans and histopathological confirmation. Each lesion was segmented, and all regions of interest were exported in a DICOM dataset. A pre-trained ResNet101 deep neural network model implemented in a previous work on 121 patients was externally validated on the current cohort to differentiate glioblastomas, PCNSLs and BMs on T1Gd-MRI scans. (3) Results: The model achieved optimal classification performance in distinguishing PCNSLs (AUC: 0.73; 95%CI: 0.62–0.85), glioblastomas (AUC: 0.78; 95%CI: 0.71–0.87) and moderate to low ability in differentiating BMs (AUC: 0.63; 95%CI: 0.52–0.76). The performance of expert neuro-radiologists on conventional plus advanced MR imaging, assessed by retrospectively reviewing the diagnostic reports of the selected cohort of patients, was found superior in accuracy for BMs (89.69%) and not inferior for PCNSL (82.90%) and glioblastomas (84.09%). (4) Conclusions: We investigated whether the previously published deep learning model was generalizable to an external population recruited at a different institution—this validation confirmed the consistency of the model and laid the groundwork for future clinical applications in brain tumour classification. This artificial intelligence-based model might represent a valuable educational resource and, if largely replicated on prospective data, help physicians differentiate glioblastomas, PCNSL and solitary BMs, especially in settings with limited resources.
- Published
- 2023
13. Vertebral Body Infarction after Transarterial Preoperative Embolization of a Vertebral Hemangioma
- Author
-
Giorgio Fiore, Giulio A. Bertani, Leonardo Tariciotti, Stefano Borsa, Aldo Paolucci, Lucia Taramasso, Marco Locatelli, and Mauro Pluderi
- Subjects
Surgery ,Neurology (clinical) - Abstract
Background Vertebral hemangioma resection can be a real challenge for spine surgeons, given the high potential of massive intraoperative bleeding. For this reason, preoperative transarterial embolization of this tumor is supported by the available literature. Here, we discuss our difficulties in interpreting an unusual clinical and radiologic picture related to the endovascular procedure. Methods and Results A 45-year-old man was referred to our department due to chronic back pain and progressive lower extremity weakness. Radiologic assessment was obtained by means of spinal computed tomography (CT) and magnetic resonance imaging (MRI), which showed an aggressive vertebral hemangioma in T7, compressing the spinal cord. The patient underwent a combined therapeutic approach consisting of preoperative transarterial embolization followed by tumor resection, spinal cord decompression, and posterior thoracic arthrodesis. The patient was dismissed with neither strength nor sensory deficits. Two weeks later, he returned to our department with fever. A new MRI demonstrated multiple areas of altered signal in almost all vertebral bodies from T6 down to the sacrum. After a deep diagnostic process, including new MRI and infectious disease evaluations, the definitive diagnosis of multiple vertebral bone infarction was suggested. Conclusion Vertebral infarctions are an extremely rare complication of spinal endovascular procedures. To our knowledge, this is the first case of multiple postembolization vertebral infarctions, without spinal cord involvement. This peculiarity was explained by the presence of direct anastomoses between a posterior intercostal artery and the underlying vertebral bodies.
- Published
- 2021
14. A supervised machine learning algorithm predicts intraoperative CSF leak in endoscopic transsphenoidal surgery for pituitary adenomas: model development and prospective validation
- Author
-
Martina Giordano, Giorgio Fiore, Giulio Bertani, Giorgio Carrabba, Giovanna Mantovani, Luigi Schisano, Stefano Borsa, Leonardo Tariciotti, Marco Locatelli, Giulia Remoli, Pierpaolo Mattogno, Valerio Maria Caccavella, and Emanuele Ferrante
- Subjects
Transsphenoidal surgery ,Leak ,business.industry ,medicine.medical_treatment ,Retrospective cohort study ,Machine learning ,computer.software_genre ,Support vector machine ,Cohort ,Medicine ,Surgery ,Model development ,Neurology (clinical) ,Artificial intelligence ,business ,F1 score ,Complication ,Algorithm ,computer - Abstract
Background Despite advances in endoscopic transnasal transsphenoidal surgery (ETNS) for pituitary adenomas (PAs), cerebrospinal fluid (CSF) leakage remains a life-threatening complication predisposing to major morbidity and mortality. In the current study we developed a supervised ML model able to predict the risk of intraoperative CSF leakage by comparing different machine learning (ML) methods and explaining the functioning and the rationale of the best performing algorithm. Methods A retrospective cohort of 238 patients treated via E-TNS for PAs was selected. A customized pipeline of several ML models was programmed and trained; the best five models were tested on a hold-out test and the best classifier was then prospectively validated on a cohort of 35 recently treated patients. Results Intraoperative CSF leak occurred in 54 (22,6%) of 238 patients. The most important risk's predictors were: non secreting status, older age, x-, y- and z-axes diameters, ostedural invasiveness, volume, ICD and R-ratio. The random forest (RF) classifier outperformed other models, with an AUC of 0.84, high sensitivity (86%) and specificity (88%). Positive predictive value and negative predictive value were 88% and 80% respectively. F1 score was 0.84. Prospective validation confirmed outstanding performance metrics: AUC (0,81), sensitivity (83%), specificity (79%), negative predictive value (95%) and F1 score (0,75). Conclusions The RF classifier showed the best performance across all models selected. RF models might predict surgical outcomes in heterogeneous multimorbid and fragile populations outperforming classical statistical analyses and other ML models (SVM, ANN etc.), improving patient management and reducing preventable morbidity and additional costs.
- Published
- 2021
- Full Text
- View/download PDF
15. Does COVID-19 affect survival and functional outcome in emergency and urgent neurosurgical procedures? A single center prospective experience during the pandemic
- Author
-
Luigi Gianmaria Remore, Luigi Schisano, Stefano Borsa, Mauro Pluderi, Giorgio Fiore, Giulio Bertani, Marco Locatelli, Leonardo Tariciotti, Giorgio Carrabba, Fiore, G, Remore, L, Tariciotti, L, Carrabba, G, Schisano, L, Pluderi, M, Bertani, G, Borsa, S, and Locatelli, M
- Subjects
Male ,Operating Rooms ,medicine.medical_treatment ,ICH, intracerebral hemorrhage ,Single Center ,KPS, Karnofsky performance status scale ,LOS, Length of in-ward stay ,Neurosurgical Procedures ,Infectious Disease Transmission, Professional-to-Patient ,COVID-19 Testing ,Pandemic ,Prospective Studies ,Craniotomy ,BH, Burr hole ,Aged, 80 and over ,Middle Aged ,Treatment Outcome ,Italy ,EVD, external ventricular drain ,Original Article ,Female ,medicine.symptom ,VPS, ventriculoperitoneal shunt ,Urgent surgery ,PPE, personal protective equipment ,Sars-Cov-2 infection ,medicine.medical_specialty ,Infectious Disease Transmission, Patient-to-Professional ,Coronavirus disease 2019 (COVID-19) ,Burr holes ,Neurosurgery ,COVID-19, Corona Virus Disease 19 ,Perioperative Care ,medicine ,OR, operating room ,Sars-CoV-2, Severe acute respiratory syndrome coronavirus 2 ,Humans ,Pandemics ,Personal Protective Equipment ,Aged ,Coma ,CSF, Cerebrospinal fluid ,Infection Control ,business.industry ,SARS-CoV-2 ,Neurological status ,COVID-19 ,Infant ,Length of Stay ,medicine.disease ,Survival Analysis ,Surgery ,Hydrocephalus ,Neurosurgical outcome ,Neurology (clinical) ,SAH, subarachnoid hemorrhage ,Emergencies ,business ,GCS, Glasgow Coma Scale score - Abstract
Objective To assess organizational and technical difficulties of neurosurgical procedures during the coronavirus disease 2019 (COVID-19) pandemic and their possible impact on survival and functional outcome and to evaluate virological exposure risk of medical personnel. Methods Data for all urgent surgical procedures performed in the COVID-19 operating room were prospectively collected. Preoperative and postoperative variables included demographics, pathology, Karnofsky performance status (KPS) and neurological status at admission, type and duration of surgical procedures, length of stay, postoperative KPS and functional outcome comparison, and destination at discharge. We defined 5 classes of pathologies (traumatic, oncological, vascular, infection, hydrocephalus) and 4 surgical categories (burr hole, craniotomy, cerebrospinal fluid shunting, spine surgery). Postoperative SARS-CoV-2 infection was checked in all the operators. Results We identified 11 traumatic cases (44%), 4 infections (16%), 6 vascular events (24%), 2 hydrocephalus conditions (8%), and 2 oncological cases (8%). Surgical procedures included 11 burr holes (44%), 7 craniotomies (28%), 6 cerebrospinal fluid shunts (24%), and 1 spine surgery (4%). Mean patient age was 57.8 years. The most frequent clinical presentation was coma (44 cases). Mean KPS score at admission was 20 ± 10, mean surgery duration was 85 ± 63 minutes, and mean length of stay was 27 ± 12 days. Mean KPS score at discharge was 35 ± 25. Outcome comparison showed improvement in 16 patients. Four patients died. Mean follow-up was 6 ± 3 months. None of the operators developed postoperative SARS-CoV-2 infection. Conclusions Standardized protocols are mandatory to guarantee a high standard of care for emergency and urgent surgeries during the COVID-19 pandemic. Personal protective equipment affects maneuverability, dexterity, and duration of interventions without affecting survival and functional outcome.
- Published
- 2021
16. A Frailty-Adjusted Stratification Score to Predict Surgical Risk, Post-Operative, Long-Term Functional Outcome, and Quality of Life after Surgery in Intracranial Meningiomas
- Author
-
Leonardo Tariciotti, Giorgio Fiore, Sara Carapella, Luigi Gianmaria Remore, Luigi Schisano, Stefano Borsa, Mauro Pluderi, Marco Canevelli, Giovanni Marfia, Manuela Caroli, Marco Locatelli, and Giulio Bertani
- Subjects
Cancer Research ,Oncology ,meningioma ,prognostic score ,skull base surgery ,frailty index ,quality of life ,functional assessment - Abstract
Object: To investigate those parameters affecting early and follow-up functional outcomes in patients undergoing resection of meningiomas and to design a dedicated predictive score, the Milan Bio(metric)-Surgical Score (MBSS) is hereby presented. Methods: Patients undergoing transcranial surgery for intracranial meningiomas were included. The most significant parameters in the regression analyses were implemented in a patient stratification score and were validated by testing its classification consistency with a clinical–radiological grading scale (CRGS), Milan complexity scale (MCS), and Charlson Comorbidity Index (CCI) scores. Results: The ASA score, Frailty index, skull base and posterior cranial fossa locations, a diameter of >25 mm, and the absence of a brain–tumour interface were predictive of early post-operative deterioration and were collected in MBSS Part A (AUC: 0.965; 95%C.I. 0.890–1.022), while the frailty index, posterior cranial fossa location, a diameter of >25 mm, a edema/tumour volume index of >2, dural sinus invasion, DWI hyperintensity, and the absence of a brain–tumour interface were predictive of a long-term unfavourable outcome and were collected in MBSS Part B (AUC: 0.877; 95%C.I. 0.811–0.942). The score was consistent with CRGS, MCS, and CCI. Conclusion: Patients’ multi-domain evaluation and the implementation of frailty indexes might help predict the perioperative complexity of cases; the functional, clinical, and neurological early outcomes; survival; and overall QoL after surgery.
- Published
- 2022
- Full Text
- View/download PDF
17. Inflammatory interactions between degenerated intervertebral discs and microglia: Implication of sphingosine-1-phosphate signaling
- Author
-
Mauro Pluderi, Jean Ouellet, Laura Riboni, Stefano Borsa, Laura Guarnaccia, Mauro Alini, Marco Locatelli, Lisbet Haglund, Chiara Gaudino, Chiara Cordiglieri, Paolo Rampini, Roberta Gualtierotti, Rolando Campanella, Giovanni Marfia, Sabino Luzzi, Giuseppe Ciniglio Appiani, and Stefania Elena Navone
- Subjects
Male ,Intervertebral Disc Degeneration ,Nitric Oxide ,Cell Line ,chemistry.chemical_compound ,Mice ,Sphingosine ,medicine ,Conditioned medium ,Animals ,Humans ,Orthopedics and Sports Medicine ,Sphingosine-1-phosphate ,Neuroinflammation ,Microglia ,Chemistry ,Chemotaxis ,Intervertebral disc ,Receptor Cross-Talk ,Middle Aged ,Sphingolipid ,Cell biology ,Crosstalk (biology) ,medicine.anatomical_structure ,Cellular Microenvironment ,Female ,Lysophospholipids - Abstract
The etiology of intervertebral disc degeneration is largely unknown, but local neuroinflammation may exert a crucial role through activation of cells as microglia and pro-inflammatory cytokines production. We aimed to compare the effect of degenerated and normal intervertebral disc microenvironment on microglial cells and the potential role of sphingosine-1-phosphate, a pro-inflammatory sphingolipid, in their crosstalk. Human degenerated intervertebral discs (Pfirrmann grade IV) were obtained at surgery for spondylolisthesis. Normal intervertebral discs were collected from cadaveric normal lumbar spines. Normal and degenerated-intervertebral discs were kept in culture to obtain media conditioning. Then, microglial cells were cocultured with conditioned media and viability, proliferation, migration, chemotaxis, and inflammatory gene expression were evaluated. The results demonstrate that conditioned media from degenerated intervertebral discs activate microglial cells, increasing chemotaxis, migration, and pro-inflammatory mediators release to a great extent than normal discs. In addition, we show that the administration of sphingosine-1-phosphate to normal intervertebral disc/microglia coculture mimicked degenerative effects. Interestingly, sphingosine-1-phosphate content in conditioned media from degenerated discs was significantly higher than that from normal ones. In addition, FTY720, a functional antagonist of sphingosine-1-phosphate, potently inhibited the effect of degenerated intervertebral discs on microglial inflammatory factor transcription and migration. Our data report, for the first time, that sphingosine-1-phosphate is involved as signal in the microenvironment of human degenerated intervertebral discs. Sphingosine-1-phosphate signaling modulation by FTY720 may induce beneficial effects in counteracting microglial activation during intervertebral disc degeneration.
- Published
- 2020
18. Impact of COVID-19 outbreak on acute low back pain
- Author
-
Mauro Pluderi, Marta Pirovano, Antonella Ampollini, Marco Locatelli, Massimo Tomei, Francesco Lombardi, Giorgio Carrabba, and Stefano Borsa
- Subjects
2019-20 coronavirus outbreak ,medicine.medical_specialty ,Letter to the editor ,Coronavirus disease 2019 (COVID-19) ,Pneumonia, Viral ,Clinical Neurology ,Neurosurgery ,Radiology, Interventional ,Article ,Disease Outbreaks ,Betacoronavirus ,Medicine ,Outpatient clinic ,Craniocerebral Trauma ,Humans ,Pandemics ,Acute low back pain ,Spinal Cord Injuries ,Cerebral Hemorrhage ,Sciatica ,business.industry ,Brain Neoplasms ,SARS-CoV-2 ,Endovascular Procedures ,Outbreak ,COVID-19 ,Subarachnoid Hemorrhage ,Low back pain ,Hospitals ,Coronavirus ,Stroke ,Italy ,Back Pain ,Spinal Injuries ,Emergency medicine ,Acute Disease ,Surgery ,Neurology (clinical) ,medicine.symptom ,Emergencies ,Intracranial Hypertension ,business ,Coronavirus Infections ,Radiology ,Low Back Pain ,Delivery of Health Care ,Spinal Cord Compression ,Hydrocephalus - Published
- 2020
19. Our darkest hours (being neurosurgeons during the COVID-19 war)
- Author
-
Giulio Bertani, Stefano Borsa, Marco Locatelli, and Mauro Pluderi
- Subjects
medicine.medical_specialty ,2019-20 coronavirus outbreak ,Neurology ,medicine.diagnostic_test ,Coronavirus disease 2019 (COVID-19) ,business.industry ,General surgery ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Clinical Neurology ,Interventional radiology ,medicine ,Surgery ,Neurology (clinical) ,Neurosurgery ,business ,Neuroradiology - Published
- 2020
- Full Text
- View/download PDF
20. Call of duty: neuro-oncology outpatient management during the COVID-19 pandemic in Milan, Italy
- Author
-
Stefano Borsa, Giulio Bertani, Marco Riva, Manuela Caroli, and Elena Pirola
- Subjects
Cancer Research ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,business.industry ,media_common.quotation_subject ,Neuro oncology ,Clinical Neurology ,MEDLINE ,Oncology ,Pandemic ,Emergency medicine ,Outpatient clinic ,Medicine ,Neurology (clinical) ,Neurosurgery ,Outpatient management ,business ,Duty ,media_common - Published
- 2020
- Full Text
- View/download PDF
21. Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?
- Author
-
Stefano Borsa, Marianna D'Anca, Anna M. Pietroboni, Milena De Riz, Laura Ghezzi, Andrea Arighi, Paolo Rampini, Maria Serpente, Marta Scarioni, Andrea Di Cristofori, Elio Scarpini, Giorgio G. Fumagalli, Chiara Fenoglio, Annalisa Colombi, Marco Locatelli, Daniela Galimberti, Giorgio Carrabba, and Tiziana Carandini
- Subjects
0301 basic medicine ,Male ,Pathology ,medicine.medical_specialty ,tau Proteins ,Disease ,03 medical and health sciences ,0302 clinical medicine ,Cerebrospinal fluid ,Normal pressure hydrocephalus ,Alzheimer Disease ,medicine ,Humans ,Aged ,Aquaporin 4 ,Amyloid beta-Peptides ,business.industry ,General Neuroscience ,Neurodegenerative Diseases ,General Medicine ,Fluid transport ,medicine.disease ,Pathophysiology ,Hydrocephalus, Normal Pressure ,Psychiatry and Mental health ,Clinical Psychology ,030104 developmental biology ,medicine.anatomical_structure ,Glymphatic system ,Female ,sense organs ,Geriatrics and Gerontology ,business ,Glymphatic System ,030217 neurology & neurosurgery ,Astrocyte - Abstract
Aquaporin4 (AQP4) is a water channel protein located at astrocyte foot processes that plays a role in glymphatic system, a highly organized fluid transport pathway which seems to be involved in Alzheimer's disease (AD) and normal pressure hydrocephalus (NPH) pathophysiology. Cerebrospinal fluid (CSF) AQP4 levels were determined in 11 patients with AD, 10 patients with NPH, and 9 controls. We found significantly reduced AQP4 in AD patients, a trend in reduction in NPH patients, and a correlation between AQP4 and amyloid-β CSF levels. This study indicates the potential role of AQP4 and glymphatic system in neurodegenerative diseases pathophysiology.
- Published
- 2019
22. Multiple vertebral metastases from brain glioblastoma: An insidious complication
- Author
-
Giulia Letizia Gribaudi, Manuela Caroli, Massimiliano Del Bene, Stefano Borsa, Sebastian Sgardello, and Elena Pirola
- Subjects
Thorax ,medicine.medical_specialty ,Temozolomide ,medicine.diagnostic_test ,business.industry ,medicine.medical_treatment ,Dura mater ,Brain Glioblastoma ,nervous system diseases ,030218 nuclear medicine & medical imaging ,Radiation therapy ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Biopsy ,medicine ,Back pain ,Abdomen ,Surgery ,Neurology (clinical) ,Radiology ,medicine.symptom ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Glioblastoma (GBM) is the most malignant and the most frequent of primary astrocytomas, typically involving the Central Nervous System (CNS) alone. Extra-CNS localizations (ECM) are exceptional, and vertebral dissemination is extremely uncommon. We present the case of a patient with vertebral dissemination from an intracranial GBM without intra-dural space invasion. The patient underwent a gross total tumor removal followed by radiation therapy (RT) with concomitant temozolomide chemotherapy (STUPP protocol). Following the appearance of back pain, patient underwent whole body computed tomography (CT) and spinal magnetic resonance imaging (MRI) scan. Spinal-MRI highlighted multiple vertebral lesions not infiltrating dura mater being confined to vertebral bodies. CT scan demonstrated the absence of other repetitive lesions in both thorax and abdomen. Histological examination from a percutaneous CT-guided vertebral biopsy confirmed the suspicious of secondary localization from intracranial GBM. To the best of our knowledge this is the second reported case of vertebral metastases from GBM in absence of other ECM. This case raises the need for clinical suspicious of vertebral dissemination in case of GBM patient presenting with radicular, myelopathic symptoms or less specifically, back pain.
- Published
- 2020
- Full Text
- View/download PDF
23. Epidemiologic and Economic Burden Attributable to First Spinal Fusion Surgery: Analysis From an Italian Administrative Database
- Author
-
Davide Cecconi, Roberto Vanelli, Stefano Borsa, Domenico Prestamburgo, Lorenzo G. Mantovani, Mauro Pluderi, Paolo Cortesi, Patrizia Tito, Fabrizio Cuzzocrea, Roberto Assietti, P Cozzolino, Giancarlo Cesana, Cortesi, P, Assietti, R, Cuzzocrea, F, Prestamburgo, D, Pluderi, M, Cozzolino, P, Tito, P, Vanelli, R, Cecconi, D, Borsa, S, Cesana, G, and Mantovani, L
- Subjects
Adult ,Male ,medicine.medical_specialty ,Spinal fusion surgery ,Databases, Factual ,medicine.medical_treatment ,MEDLINE ,Scoliosis ,03 medical and health sciences ,0302 clinical medicine ,Environmental health ,Epidemiology ,medicine ,Humans ,Orthopedics and Sports Medicine ,030212 general & internal medicine ,Economic impact analysis ,Aged ,Retrospective Studies ,business.industry ,Incidence (epidemiology) ,Retrospective cohort study ,Health Care Costs ,Middle Aged ,medicine.disease ,Spinal Fusion ,Italy ,Spinal fusion ,Physical therapy ,Female ,Neurology (clinical) ,business ,030217 neurology & neurosurgery - Abstract
Study Design. Retrospective large population based-study. Objective. Assessment of the epidemiologic trends and economic burden of first spinal fusions. Summary of Background Data. No adequate data are available regarding the epidemiology of spinal fusion surgery and its economic impact in Europe. Methods. The study population was identified through a data warehouse (DENALI), which matches clinical and economic data of different Healthcare Administrative databases of the Italian Lombardy Region. The study population consisted of all subjects, resident in Lombardy, who, during the period January 2001 to December 2010, underwent spinal fusion surgery (ICD-9-CM codes: 81.04, 81.05, 81.06, 81.07, and 81.08). The first procedure was used as the index event. We estimated the incidence of first spinal fusion surgery, the population and surgery characteristics and the healthcare costs from the National Health Service's perspective. The analysis was performed for the entire population and divided into the main groups of diagnosis. Results. The analysis identified 17,772 [mean age (SD): 54.6 (14.5) years, 55.3% females] spinal fusion surgeries. Almost 67% of the patients suffered from a lumbar degenerative disease. The incidence rate of interventions increased from 11.5 to 18.5 per 100,000 person-year between 2001 and 2006, and was above 20.0 per 100,000 person-year in the last 4 years. The patients' mean age increased during the observational time period from 48.1 to 55.9 years; whereas the median hospital length of stay reported for the index event decreased. The average cost of the spinal fusion surgery increased during the observational period, from € 4726 up to € 9388. Conclusion. The study showed an increasing incidence of spinal fusion surgery and costs from 2001 to 2010. These results can be used to better understand the epidemiological and economic burden of these interventions, and help to optimize the resources available considering the different clinical approaches accessible today.
- Published
- 2017
24. 'The Mute Who Can Sing': a cortical stimulation study on singing
- Author
-
Jean-François Démonet, Stefano Borsa, and Franck-Emmanuel Roux
- Subjects
medicine.medical_specialty ,animal structures ,business.industry ,Audiology ,humanities ,Sensorimotor Areas ,nervous system ,behavior and behavior mechanisms ,Medicine ,Singing ,business ,Awake surgery ,Amateur ,psychological phenomena and processes - Abstract
Object In an attempt to identify cortical areas involved in singing in addition to language areas, the authors used a singing task during direct cortical mapping in 5 patients who were amateur singers and had undergone surgery for brain tumors. The organization of the cortical areas involved in language and singing was analyzed in relation with these surgical data. Methods One left-handed and 4 right-handed patients with brain tumors in left (2 cases) and right (3 cases) hemispheres and no significant language or singing deficits underwent surgery with the “awake surgery” technique. All patients had a special interest in singing and were involved in amateur singing activities. They were tested using naming, reading, and singing tasks. Results Outside primary sensorimotor areas, singing interferences were rare and were exclusively localized in small cortical areas (< 1 cm2). A clear distinction was found between speech and singing in the Broca region. In the Broca region, no singing interference was found in areas in which interference in naming and reading tasks were detected. Conversely, a specific singing interference was found in nondominant middle frontal gyri in one patient. This interference consisted of abrupt singing arrest without apparent face, mouth, and tongue contraction. Finally, nonspecific singing interferences were found in the right and left precentral gyri in all patients (probably by interference in final articulatory mechanisms of singing). Conclusions Dissociations between speech and singing found outside primary sensorimotor areas showed that these 2 functions use, in some cortical stages, different cerebral pathways.
- Published
- 2009
- Full Text
- View/download PDF
25. Atypical Association of Ethmoidal Encephalocele and Hydrocephalus in an Adult Patient with Autosomal-Dominant Osteopetrosis Type I (ADO-I): A Case Report
- Author
-
Andrea Di Cristofori, Stefano Borsa, Marco Locatelli, Carlotta Castellani, Zefferino Rossini, Giorgio Carrabba, Rossini, Z, Castellani, C, Borsa, S, Carrabba, G, Locatelli, M, and Di Cristofori, A
- Subjects
medicine.medical_specialty ,Tomography Scanners, X-Ray Computed ,Subarachnoid hemorrhage ,Ethmoidal encephalocele ,Exophthalmos ,Communicating hydrocephalu ,Meningocele ,030218 nuclear medicine & medical imaging ,Encephalocele ,Intracranial hypertension ,03 medical and health sciences ,Osteosclerosis ,0302 clinical medicine ,medicine ,Humans ,Autosomal-dominant osteopetrosis type I (ADO-I) ,business.industry ,TNS surgery ,Ethmoid bone ,Osteopetrosis ,Middle Aged ,medicine.disease ,Magnetic Resonance Imaging ,Surgery ,Hydrocephalus ,Ethmoid Bone ,Skull ,medicine.anatomical_structure ,Female ,Neurology (clinical) ,medicine.symptom ,business ,Magnetic Resonance Angiography ,030217 neurology & neurosurgery - Abstract
Background Osteopetroses are a heterogeneous group of heritable disorders characterized by increased bone density as the result of defective osteoclast-mediated bone resorption. The autosomal-dominant osteopetrosis type I (ADO-I) is defined by the presence of osteosclerosis involving mainly the skull bones, variably associated with compression of the foramina of cranial nerves and vascular structures, hypertelorism, exophthalmos, and less commonly with hydrocephalus, pseudotumor, and Chiari malformation type I. Case Description We describe an adult patient with ADO-I presenting with an atypical association of clinical manifestations that required a tailored management. On admission, the patient complained about chronic headache, recurrent sinusitis, and postnasal drip. Findings of the examination didn't show clear signs of increased intracranial pressure, whereas imaging studies revealed thickening of the skull bones and an unexpected fistula associated with anterior ethmoidal meningoencephalocele. Some days after endoscopic transnasal closure of the fistula, a severe hypertensive hydrocephalus developed, which required a prompt ventriculoperitoneal shunt placement, complicated by a diffuse subarachnoid hemorrhage. The 6-month follow-up showed complete recovery. Conclusions After reviewing the literature, we can confirm that ours was the second case of an adult ADO-I patient associated with anterior ethmoidal meningoencephalocele, the first one needing a combined treatment of the encephalocele and hydrocephalus. Because ADO-I is a rare disease with a wide spectrum of clinical manifestations, our case can represent a prototype for the future management of similar cases.
- Published
- 2016
26. Thermodynamics-based indicators for environmental management and sustainability policies
- Author
-
Stefano Borsa, Valentina Niccolucci, Federico Maria Pulselli, and Nadia Marchettini
- Subjects
territorial planning ,emergy evaluation ,indicators ,resource management ,Economics ,Environmental economics - Published
- 2010
- Full Text
- View/download PDF
27. 'The mute who can sing': a cortical stimulation study on singing
- Author
-
Franck-Emmanuel, Roux, Stefano, Borsa, and Jean-François, Démonet
- Subjects
Adult ,Cerebral Cortex ,Male ,Brain Mapping ,Brain Neoplasms ,Middle Aged ,Reading ,Voice ,Humans ,Speech ,Female ,Prospective Studies ,Dominance, Cerebral ,Music ,Neuronavigation ,Aged - Abstract
In an attempt to identify cortical areas involved in singing in addition to language areas, the authors used a singing task during direct cortical mapping in 5 patients who were amateur singers and had undergone surgery for brain tumors. The organization of the cortical areas involved in language and singing was analyzed in relation with these surgical data.One left-handed and 4 right-handed patients with brain tumors in left (2 cases) and right (3 cases) hemispheres and no significant language or singing deficits underwent surgery with the "awake surgery" technique. All patients had a special interest in singing and were involved in amateur singing activities. They were tested using naming, reading, and singing tasks.Outside primary sensorimotor areas, singing interferences were rare and were exclusively localized in small cortical areas (1 cm(2)). A clear distinction was found between speech and singing in the Broca region. In the Broca region, no singing interference was found in areas in which interference in naming and reading tasks were detected. Conversely, a specific singing interference was found in nondominant middle frontal gyri in one patient. This interference consisted of abrupt singing arrest without apparent face, mouth, and tongue contraction. Finally, nonspecific singing interferences were found in the right and left precentral gyri in all patients (probably by interference in final articulatory mechanisms of singing).Dissociations between speech and singing found outside primary sensorimotor areas showed that these 2 functions use, in some cortical stages, different cerebral pathways.
- Published
- 2008
28. Temozolomide in glioblastoma: results of administration at first relapse and in newly diagnosed cases. Is still proposable an alternative schedule to concomitant protocol?
- Author
-
Sergio M. Gaini, Francesco Prada, Annarita Mora, F. Motta, Rolando Campanella, Marco Locatelli, Manuela Caroli, Filippo Martinelli-Boneschi, Andrea Saladino, and Stefano Borsa
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,Disease-Free Survival ,Drug Administration Schedule ,Statistics, Nonparametric ,Quality of life ,medicine ,Temozolomide ,Humans ,Karnofsky Performance Status ,Antineoplastic Agents, Alkylating ,Aged ,Chemotherapy ,Mini–Mental State Examination ,medicine.diagnostic_test ,business.industry ,Brain Neoplasms ,Middle Aged ,Surgery ,Clinical trial ,Radiation therapy ,Dacarbazine ,Regimen ,Treatment Outcome ,Neurology ,Oncology ,Concomitant ,Female ,Neurology (clinical) ,Neoplasm Recurrence, Local ,business ,Glioblastoma ,medicine.drug - Abstract
To evaluate if timing of chemotherapy with Temozolomide (TMZ) was able to modify the outcome of glioblastoma (GBM), we analyzed two comparable series of supratentorial GBM patients, treated with surgery and radiotherapy, in which the administration of TMZ has been performed in the first group at first relapse and in the second group in newly diagnosed cases. The end-points were the median survival, the time tumor progression (TTP) and also the Karnofsky (KPS) scale and the Mini Mental State Examination (MMSE) scale at follow-up. From December 1999 to December 2001 30 patients with recurrent GBM received TMZ until progression. From January 2002 to January 2004 38 newly diagnosed patients received a first cycle of TMZ immediately after surgery, and additional cycles after completing radiotherapy until recurrence. In order to obtain a greater drug exposure we adopted a once-daily 10 days schedule of TMZ every 28 days as follows: 150 mg/m(2)/day (day 1-5) and 75 mg/m(2)/day (day 6-10). The first group had a median overall survival of 14 months and a median TTP of 6. The second group had a median survival of 16 months and a median TTP of 10. The difference of TTP was statistically significant (P < 0.001), while the overall survival was not. The values of KPS and MMSE at 12 months demonstrated a better quality of life in the second group (P < 0.01). Our regimen permitted to cover the therapeutic "window" between surgery and the beginning of radiotherapy in newly diagnosed cases and is well tolerated by the patients with limited side effects. We will propose as alternative option when the concomitant radio-chemotherapic protocol is not feasible.
- Published
- 2006
29. Temozolomide in glioblastoma: results of administration at first relapse and in newly diagnosed cases. Is still proposable an alternative schedule to concomitant protocol?
- Author
-
Manuela Caroli, Marco Locatelli, Rolando Campanella, Federica Motta, Annarita Mora, Francesco Prada, Stefano Borsa, Filippo Martinelli-Boneschi, Andrea Saladino, and Sergio Gaini
- Abstract
Abstract  To evaluate if timing of chemotherapy with Temozolomide (TMZ) was able to modify the outcome of glioblastoma (GBM), we analyzed two comparable series of supratentorial GBM patients, treated with surgery and radiotherapy, in which the administration of TMZ has been performed in the first group at first relapse and in the second group in newly diagnosed cases. The end-points were the median survival, the time tumor progression (TTP) and also the Karnofsky (KPS) scale and the Mini Mental State Examination (MMSE) scale at follow-up. From December 1999 to December 2001 30 patients with recurrent GBM received TMZ until progression. From January 2002 to January 2004 38 newly diagnosed patients received a first cycle of TMZ immediately after surgery, and additional cycles after completing radiotherapy until recurrence. In order to obtain a greater drug exposure we adopted a once-daily 10 days schedule of TMZ every 28 days as follows: 150 mg/m2/day (day 1â5) and 75 mg/m2/day (day 6â10). The first group had a median overall survival of 14 months and a median TTP of 6. The second group had a median survival of 16 months and a median TTP of 10. The difference of TTP was statistically significant (P P Our regimen permitted to cover the therapeutic âwindowâ between surgery and the beginning of radiotherapy in newly diagnosed cases and is well tolerated by the patients with limited side effects. We will propose as alternative option when the concomitant radio-chemotherapic protocol is not feasible. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
30. Sustainability indicators for environmental performance and sustainability assessment of the productions of four fine Italian wines
- Author
-
Valentina Niccolucci, Nadia Marchettini, Simone Bastianoni, Margherita Panzieri, and Stefano Borsa
- Subjects
Resource (biology) ,Emergy analysis ,Natural resource economics ,business.industry ,media_common.quotation_subject ,Geography, Planning and Development ,Environmental resource management ,Environmental certification ,Management, Monitoring, Policy and Law ,Emergy ,Environmental Sustainability Index ,Agriculture ,Sustainability ,Sustainability indicators ,Long-term sustainability ,Thermodynamic analysis ,Quality (business) ,Agricultural productivity ,business ,media_common - Abstract
SUMMARY Increased awareness of the importance of environmental protection and the introduction of international standards like ISO 14001 stimulated development of environmental sustainability indicators as a means to measure systems environmental performance. Here, a thermodynamic approach, emergy analysis (Odum, 1988) was used to obtain sustainability indicators able to analyse and quantify the productive and ecological performance of four famous Italian wine productions: Chianti, Brunello di Montalcino, Nobile di Montepulciano, and Barbera d'hti. The application to agricultural production was motivated by the growing need for productive and environmentally sound development in modern agriculture, in which the resource base, the environment, is preserved. The choice of wines, more precisely, grape production, is due to their importance for Italian agriculture and the economy. All the wines demonstrated a good long-term environmental sustainability, especially in view of their high quality and in comparis...
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.